Concerns in a primary care population about genetic discrimination by insurers

Genetics in Medicine - Tập 7 Số 5 - Trang 311-316 - 2005
Mark A. Hall1, Jean E. McEwen2, James C. Barton3, Ann P. Walker4, Edmund G. Howe5, Jacob A. Reiss6, Tara E. Power7, Shellie D. Ellis1, Diane C. Tucker8, Barbara Harrison9, Gordon D. McLaren4,10, Andrea Ruggiero1, Elizabeth J. Thomson2
1Wake Forest University, Winston-Salem
2National Institutes of Health–National Human Genome Research Institute, Bethesda
3Southern Iron Disorders Center, Birmingham
4University of California, Irvine
5Uniformed Services University of the Health Sciences, Bethesda
6Kaiser Permanente Northwest, Portland
7London (Ontario) Health Sciences Center, Canada
8University of Alabama at Birmingham
9Howard University, Washington
10Veterans Affairs Long Beach Healthcare System, Long Beach

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hall

Collins

Rothenberg

Hellman

Matloff

Pfeffer

Cho

Lapham

Apse

Hadley

Geer

Armstrong

Peterson, 2002, Health insurance and discrimination concerns and BRCA 1/2 testing in a clinic population, Cancer Epidemiol Biomarkers Prev, 11, 79

Lynch, 1997, A descriptive study of BRCA1 testing and reactions to disclosure of test results, Cancer, 79, 2228, 10.1002/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y

Thompson

Rothstein MA. Pharmacogenomics: Social, ethical, and clinical dimensions. New York: John Wiley & Sons, 2003.

Singer

Rothstein MA. Genetics and life insurance. Cambridge, Mass: MIT Press, 2004.

Mayer RN, Smith NR, Zick CD, Botkin JR. Coercion, control, and consequence in genetic testing. In: Thompson AK, Chadwick RF, eds. Genetic information. New York: Kluwer Academic/Plenum Publishing, 1999: 41–56.

McLaren

Hays

Krieger

Krieger

Klanica K. Genetic information and health insurance: a report on law and legislation in the United States. Boston, Mass: Council for Responsible Genetics, 2004.